News
September 26, 2016
Biogen Completes Rolling Submission of New Drug Application to FDA for Nusinersen as a Treatment for Spinal Muscular AtrophySeptember 22, 2016
Akcea Announces Publication in The Lancet of Clinical Results with Lp(a)-Lowering Drugs Designed to Treat Cardiovascular Disease
Spotlight
CHMP of the EMA has Granted Nusinersen Accelerated Assessment
More »
Ionis Receives Drug Discovery Award to Support Cystic Fibrosis Research
More »
Newly Published Data Demonstrate a Novel Pro-inflammatory Mechanism for Lp(a) in Humans
More »
Newly Published Nusinersen Clinical Data Highlight Positive Data in Children with Spinal Muscular Atrophy
More »
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
Events
No upcoming events at this time...